Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. M. Garcia Gimeno"'
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The global increase in antimicrobial resistance makes it necessary to establish local protocols for the empirical treatment of the different syndromes in hospitals to preserve and optimise the use of antibiotics as much as p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0de458ee2e318be7576329303b461d8
https://doi.org/10.1136/ejhpharm-2021-eahpconf.82
https://doi.org/10.1136/ejhpharm-2021-eahpconf.82
Publikováno v:
Section 2: Selection, procurement and distribution.
Background and importance Because of the current pandemic, it was necessary to create an intensive care unit (ICU) in our hospital. This meant an increase in the consumption of propofol and the associated supply problems. It was necessary to develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e62e6f2ea9e71f8614b556e9d2958ee5
https://doi.org/10.1136/ejhpharm-2021-eahpconf.19
https://doi.org/10.1136/ejhpharm-2021-eahpconf.19
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Tocilizumab is an immunosuppressive agent, an inhibitor of interleukin 6. In March 2020, it was included in the treatment plan of SARS-CoV-2 infection with the aim of slowing down the inflammatory phase. Therefore, tocilizum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f26848fa8b1b5ca506984d9553aa7e72
https://doi.org/10.1136/ejhpharm-2021-eahpconf.290
https://doi.org/10.1136/ejhpharm-2021-eahpconf.290